169 related articles for article (PubMed ID: 10449950)
1. Mycosis fungoides in patients under 20 years of age: report of 7 cases, review of the literature and study of the clinical course.
Quaglino P; Zaccagna A; Verrone A; Dardano F; Bernengo MG
Dermatology; 1999; 199(1):8-14. PubMed ID: 10449950
[TBL] [Abstract][Full Text] [Related]
2. Unilesional mycosis fungoides: a study of seven cases.
Hodak E; Phenig E; Amichai B; Feinmesser M; Kuten A; Maron L; Sahar D; Bergman R; David M
Dermatology; 2000; 201(4):300-6. PubMed ID: 11146338
[TBL] [Abstract][Full Text] [Related]
3. [Mycosis fungoides in children and adolescents: a report of six cases with predominantly hypopigmentation, along with a literature review].
Rizzo FA; Vilar EG; PantaleĆ£o L; Fonseca EC; Magrin PF; Henrique-Xavier M; Rochael MC
Dermatol Online J; 2012 Mar; 18(3):5. PubMed ID: 22483516
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and course of CD8+ cytotoxic variant of mycosis fungoides: a case series of seven patients.
Nikolaou VA; Papadavid E; Katsambas A; Stratigos AJ; Marinos L; Anagnostou D; Antoniou C
Br J Dermatol; 2009 Oct; 161(4):826-30. PubMed ID: 19558552
[TBL] [Abstract][Full Text] [Related]
5. Outcome in 34 patients with juvenile-onset mycosis fungoides: a clinical, immunophenotypic, and molecular study.
Wain EM; Orchard GE; Whittaker SJ; Spittle M Sc MF; Russell-Jones R
Cancer; 2003 Nov; 98(10):2282-90. PubMed ID: 14601100
[TBL] [Abstract][Full Text] [Related]
6. Influence of the phenotype on mycosis fungoides prognosis, a retrospective cohort study of 160 patients.
Jaque A; Mereniuk A; Walsh S; Shear NH; Sade S; Zagorski B; Alhusayen R
Int J Dermatol; 2019 Aug; 58(8):933-939. PubMed ID: 30761533
[TBL] [Abstract][Full Text] [Related]
7. Poikilodermatous mycosis fungoides: a study of its clinicopathological, immunophenotypic, and prognostic features.
Abbott RA; Sahni D; Robson A; Agar N; Whittaker S; Scarisbrick JJ
J Am Acad Dermatol; 2011 Aug; 65(2):313-319. PubMed ID: 21529998
[TBL] [Abstract][Full Text] [Related]
8. Clinical presentation, immunopathology, and treatment of juvenile-onset mycosis fungoides: a case series of 34 patients.
Boulos S; Vaid R; Aladily TN; Ivan DS; Talpur R; Duvic M
J Am Acad Dermatol; 2014 Dec; 71(6):1117-26. PubMed ID: 25264240
[TBL] [Abstract][Full Text] [Related]
9. Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: a multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas.
Quaglino P; Pimpinelli N; Berti E; Calzavara-Pinton P; Alfonso Lombardo G; Rupoli S; Alaibac M; Bottoni U; Carbone A; Fava P; Fimiani M; Mamusa AM; Titli S; Zinzani PL; Bernengo MG;
Cancer; 2012 Dec; 118(23):5830-9. PubMed ID: 22674564
[TBL] [Abstract][Full Text] [Related]
10. CD4/CD8 double-negative epidermotropic cutaneous T-cell lymphoma: an immunohistochemical variant of mycosis fungoides.
Hodak E; David M; Maron L; Aviram A; Kaganovsky E; Feinmesser M
J Am Acad Dermatol; 2006 Aug; 55(2):276-84. PubMed ID: 16844512
[TBL] [Abstract][Full Text] [Related]
11. Canine cutaneous epitheliotropic lymphoma (mycosis fungoides) is a proliferative disorder of CD8+ T cells.
Moore PF; Olivry T; Naydan D
Am J Pathol; 1994 Feb; 144(2):421-9. PubMed ID: 7906096
[TBL] [Abstract][Full Text] [Related]
12. CD20+ mycosis fungoides: a report of three cases and review of the literature.
Hagen JW; Schaefer JT; Magro CM
Am J Dermatopathol; 2013 Dec; 35(8):833-41. PubMed ID: 24247573
[TBL] [Abstract][Full Text] [Related]
13. Hypopigmented mycosis fungoides versus mycosis fungoides with concomitant hypopigmented lesions: same disease or different variants of mycosis fungoides?
Furlan FC; Pereira BA; Sotto MN; Sanches JA
Dermatology; 2014; 229(3):271-4. PubMed ID: 25323446
[TBL] [Abstract][Full Text] [Related]
14. CD8
Martinez-Escala ME; Kantor RW; Cices A; Zhou XA; Kaplan JB; Pro B; Choi J; Guitart J
J Am Acad Dermatol; 2017 Sep; 77(3):489-496. PubMed ID: 28676328
[TBL] [Abstract][Full Text] [Related]
15. A study of clinicopathologic profile of 15 cases of hypopigmented mycosis fungoides.
Khopkar U; Doshi BR; Dongre AM; Gujral S
Indian J Dermatol Venereol Leprol; 2011; 77(2):167-73. PubMed ID: 21393946
[TBL] [Abstract][Full Text] [Related]
16. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
Bosisio FM; Cerroni L
Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
[TBL] [Abstract][Full Text] [Related]
17. Juvenile mycosis fungoides: cutaneous T-cell lymphoma with frequent follicular involvement.
Hodak E; Amitay-Laish I; Feinmesser M; Davidovici B; David M; Zvulunov A; Pavlotsky F; Yaniv I; Avrahami G; Ben-Amitai D
J Am Acad Dermatol; 2014 Jun; 70(6):993-1001. PubMed ID: 24629999
[TBL] [Abstract][Full Text] [Related]
18. Low CD7 expression in benign and malignant cutaneous lymphocytic infiltrates: experience with an antibody reactive with paraffin-embedded tissue.
Murphy M; Fullen D; Carlson JA
Am J Dermatopathol; 2002 Feb; 24(1):6-16. PubMed ID: 11803274
[TBL] [Abstract][Full Text] [Related]
19. CD4+, CD56+ mycosis fungoides: case report and review of the literature.
Horst BA; Kasper R; LeBoit PE
Am J Dermatopathol; 2009 Feb; 31(1):74-6. PubMed ID: 19155730
[TBL] [Abstract][Full Text] [Related]
20. Hypopigmented mycosis fungoides: frequent expression of a CD8+ T-cell phenotype.
El-Shabrawi-Caelen L; Cerroni L; Medeiros LJ; McCalmont TH
Am J Surg Pathol; 2002 Apr; 26(4):450-7. PubMed ID: 11914622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]